Alzheimer's Drug Discovery Foundation at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

Alzheimer's Drug Discovery Foundation takes part in 2 sessions at CTAD 2026 in Boston. Its program centres on plasma proteomics and speech as markers of Alzheimer's disease. Its work draws on the Global Neurodegeneration Proteomics Consortium dataset and the SpeechDx project on prognostic speech markers.

OrganizationCTAD 2026 Attendance
◆Ultimate Sponsor
alzdiscovery.org
Foundations & non-profitsUltimate Sponsor
Venture-philanthropy foundation funding Alzheimer's drug and biomarker development; runs the Diagnostics Accelerator.
Talk
Wed Nov 18
12:10pm
Poster
Thu Nov 19
7:15am–5:00pm

Explore the full CTAD 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full CTAD 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Alzheimer's Drug Discovery Foundation

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction